Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial | American Journal of Psychiatry March 25, 2018Dr. Joris Wiggers https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2017.17030325 Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Like Loading... Related
Dr. Joris Wiggers 